Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors
- 13 May 2003
- journal article
- review article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 11 (13), 2663-2676
- https://doi.org/10.1016/s0968-0896(03)00161-5
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Allosteric Regulation of CCR5 by Guanine Nucleotides and HIV-1 EnvelopeBiochemical and Biophysical Research Communications, 2001
- Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsinJournal of Molecular Biology, 1998
- Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32Journal of Biological Chemistry, 1997
- HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5Published by Elsevier BV ,1997
- CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5Nature, 1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesCell, 1996
- Proteins-Paradigms of complex systemsCellular and Molecular Life Sciences, 1995
- Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp!20 geneNature, 1991
- HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domainNature, 1990